Design, Synthesis, Pharmacological Evaluation, In silico Modeling, Prediction of Toxicity and Metabolism Studies of Novel 1-(substituted)-2-methyl- 3-(4-oxo-2-phenyl quinazolin-3(4H)-yl)isothioureas
作者:Mohaideen Thasthagir Sulthana、Veerachamy Alagarsamy、Krishnan Chitra
DOI:10.2174/1573406416666200817153033
日期:2021.5
virus (HIV) activity by MT-4 cell assay method. The agar dilution method was used to test the antibacterial potency of entire prepared derivatives against various strains of grampositive and gram-negative microorganisms. RESULTS The title compounds, 1-(substituted)-2-methyl-3-(4-oxo-2-phenyl quinazolin-3(4H)-yl) isothioureas (QTS1 - QTS15) were synthesized by the reaction between key intermediate 3-amino-
背景虽然已经为预防和治疗结核病(TB)做出了详尽的努力,但由于耐多药(MDR)和广泛耐药结核病(XDR-TB),该问题仍然存在。它清楚地强调了开发用于 MDR-TB 和 XDR-TB 共感染治疗和菌株的新型“可成药”分子的迫切需要。目标在该方法中,通过合并两个或多个药效团来创建混合分子。目标的活性位点可以由每个药效团寻址并提供选择性的机会。此外,它还减少了不良副作用和耐药性。方法在本研究中,通过分别在喹唑啉环的N-3和C-2位取代硫脲核和苯环,设计并合成了一种新型喹唑啉酮类似物。通过体外结核分枝杆菌测试了所有标题化合物的抗结核活性,并通过 MT-4 细胞分析方法测试了抗人类免疫缺陷病毒 (HIV) 活性。琼脂稀释法用于测试整个制备的衍生物对各种革兰氏阳性和革兰氏阴性微生物菌株的抗菌效力。结果 通过关键中间体 3-氨基-2-苯基喹唑啉-4(3H)-一种与各种烷基/芳基异硫氰酸酯,然后用硫酸二甲酯甲基化。在该系列中,化合物